Skip to main content
. 2015 Jun 17;36(2):363–368. doi: 10.3892/ijmm.2015.2251

Figure 5.

Figure 5

Effects of recombinant human lactoferrin (rhLf) on the inflammatory response in mice infected with H. pylori. (A) Stomach tissues from the mice infected with H. pylori were assessed by H&E staining (left panel). The inflammation classified by the histological score was measured (right panel) (n=48 in each group). (B) The levels of tumor necrosis factor α (TNFα) and interleukin 8 (IL-8) in the stomach tissues were determined by ELISA. Bars labeled A represent the control, bars labeled B represent the rhLF-treated group, bars labeled C represent the group treated with the standard triple therapy regimen, and bars labeled D represent the group treated with the standard triple therapy regimen + rhLF. *P<0.05 and **P<0.01 vs. the group treated with standard triple therapy regimen alone.